Status:
ACTIVE_NOT_RECRUITING
A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test
Lead Sponsor:
Novomics. Co., Ltd.
Conditions:
Gastric Cancer
Eligibility:
All Genders
19+ years
Brief Summary
Precision medicine approaches emphasize the importance of reliable prognostic tools for guiding individualized therapy decisions. In this study, we evaluated the clinical feasibility of the Single Pat...
Detailed Description
A prospective multicenter study was conducted, involving 237 patients who underwent gastrectomy between September 2019 and August 2020 across nine hospitals. The SPC test was employed to stratify pati...
Eligibility Criteria
Inclusion
- being ≥19 years of age
- having a histologically confirmed diagnosis of stage II or III AGC according to the American Joint Committee on Cancer (AJCC) staging system (sixth edition)
- underwent radical gastrectomy without prior neo-adjuvant chemoradiotherapy and did not receive adjuvant chemotherapy
- having no visually or microscopically detectable residual tumors.
Exclusion
- Those with insufficient quantity or quality of ribonucleic acid (RNA) for analysis were excluded from the study.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT06521528
Start Date
September 1 2019
End Date
December 31 2025
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novomics. Co., Ltd.
Seoul, South Korea, 07217